Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is a malignant tumor with great variation in prognosis among individuals. Changes in metabolism influence disease progression and clinical outcomes. The objective of this study was to determine the overall survival (OS) risk of HCC patients from a metabolic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Hepatocell Carcinoma
Hauptverfasser: Weng, Jialei, Zhou, Chenhao, Zhou, Qiang, Chen, Wanyong, Yin, Yirui, Atyah, Manar, Dong, Qiongzhu, Shi, Yi, Ren, Ning
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove 2021
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8018394/
https://ncbi.nlm.nih.gov/pubmed/33824863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S300633
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge